Author:
Pleyer U.,Mackensen F.,Winterhalter S.,Stübiger N.
Publisher
Springer Science and Business Media LLC
Reference43 articles.
1. Accorinti M, Pirraglia MP, Paroli MP et al (2007) Infliximab treatment for ocular and extraocular manifestations of Behçet’s disease. Jpn J Ophthalmol 51:191–196
2. Agarwal PK, Gallaghar M, Murphy E, Virdi M (2007) Endogenous endophthalmitis in a rheumatoid patient on tumor necrosis factor alpha blocker. Indian J Ophthalmol 55:230–232
3. Beutler B, Cerami A (1988) The history, properties, and biological effects of cachectin. Biochemistry 27:7575–7582
4. Braun J, Baraliakos X, Listing J, Sieper J (2005) Decreased incidence of anterior uveitis in patients with ankylosing spondylitis treated with the anti-tumor necrosis factor agents infliximab and etanercept. Arthritis Rheum 52:2447–2451
5. Brito BE, O’Rourke LM, Pan Y et al (1999) IL-1 and TNF receptor-deficient mice show decreased inflammation in an immune complex model of uveitis. Invest Ophthalmol Vis Sci 40:2583–2589
Cited by
10 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献